Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes.
Saved in:
| Title: | Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes. |
|---|---|
| Authors: | Flori, Lorenzo1 (AUTHOR) lorenzo.flori@farm.unipi.it, Brogi, Simone1,2 (AUTHOR) h_sirous@pharm.mui.ac.ir, Sirous, Hajar2 (AUTHOR), Calderone, Vincenzo1 (AUTHOR) |
| Source: | International Journal of Molecular Sciences. Apr2023, Vol. 24 Issue 8, p7578. 23p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16616596 |
|---|---|
| DOI: | 10.3390/ijms24087578 |
